| Metric | Q2'25 | Q3'25 | Change |
|---|---|---|---|
| Total Revenue | $973M (+10% YoY) | $988M (+10% YoY) | YoY growth held despite comps |
| EPS | $1.77 | $1.93 | +9% sequential beat |
| Semiconductor Revenue | $432M (+17% YoY) | $415M (+10% YoY) | 700 bps YoY deceleration |
| E&P Revenue | $266M (+16% YoY) | $289M (+25% YoY) | +900 bps YoY acceleration |
| Specialty Industrial | $275M (-5% YoY) | $284M (-1% YoY) | Improving but still negative |
| Gross Margin | 46.6% | 46.6% | Flat despite mix headwinds |
| Operating Margin | 20.8% | 20.8% | Held the line |
| Free Cash Flow | $136M (14% of rev) | $147M (15% of rev) | +100 bps FCF margin expansion |
| Net Leverage Ratio | 4.0x | 3.9x | Deleveraging continues |
| Chemistry Revenue Growth | +10% YoY ex-FX | Not disclosed | Metric disappeared |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.